Clinical Trials
19 trialsNCT05418959 2026-05-22
Genetic Risk Stratification of Pediatric Skin Lesions
Massachusetts General Hospital
Phase 1 Enrolling by invitation
NCT04399876 2026-05-18
Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer
Brigham and Women's Hospital
Phase 1 Enrolling by invitation
NCT07583160 2026-05-13
YS247
Changhai Hospital
Phase 1 Enrolling by invitation
NCT03054792 2026-04-29
Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas
The Hospital for Sick Children
Phase 1 Enrolling by invitation
NCT03170141 2026-04-24
Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
Shenzhen Geno-Immune Medical Institute
Phase 1 Enrolling by invitation
NCT06300502 2026-04-22
Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)
Massachusetts General Hospital
Phase 1 Enrolling by invitation
NCT07353294 2026-04-22
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1 Enrolling by invitation
NCT07488312 2026-04-20
LUCENT-GC-01
Qilu Hospital of Shandong University
Phase 1 Enrolling by invitation
NCT05635591 2026-04-08
KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial
Tongji Hospital
Phase 1 Enrolling by invitation
NCT07080463 2026-03-10
VascuLens RCT
University of British Columbia
Phase 1 Enrolling by invitation
NCT06508138 2026-03-06
J21112LINKED
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Enrolling by invitation
NCT05746104 2026-01-22
Second Window Indocyanine Green for All Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Phase 1 Enrolling by invitation
NCT07014462 2025-10-06
DLIT-AML
University of Vermont
Phase 1 Enrolling by invitation
NCT06882876 2025-09-19
JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study
Xiangya Hospital of Central South University
Phase 1 Enrolling by invitation
NCT07168486 2025-09-11
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
University of Maryland, Baltimore
Phase 1 Enrolling by invitation
NCT05937269 2025-09-09
Assessing Impact of Early Physiotherapy on Lymphatic Dysfunction in Head and Neck Cancer Survivorship
The University of Texas Health Science Center, Houston
Phase 1 Enrolling by invitation
NCT06827782 2025-08-15
Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1 Enrolling by invitation
NCT06896110 2025-06-26
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
University of Iowa
Phase 1 Enrolling by invitation
NCT06671691 2024-11-04
DESERT-I
Universitat de les Illes Balears
Phase 1 Enrolling by invitation